REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

London pre-open: Footsie points higher

Fri, 26th Jun 2009 07:36

London's blue chips look set to open higher after Wall Street closed up 2% last night. Traders expect Footsie to gain 35 points in early dealings.London-listed drugs giant AstraZeneca and US pharmaceuticals major Bristol-Myers Squibb said their jointly developed treatment for type 2 diabetes has cleared a regulatory hurdle in Europe.Profits tumbled last year at Berkeley but the London and South East -focused housebuilder reports some stability returning to the market in the last three months. Laundry and workwear group Davis Service said revenue in the first five month of the year was ahead of 2008 while operating profit was broadly in line with a strong comparable period, benefiting from favourable foreign exchange translation. Filtrona's overall performance in the year to date has been in line with expectations and the filters group said its restructuring programmes are progressing well. Port operator Forth Ports said its results for the first half of the year are expected to be in line with last year with the exception of its materials recycling business and its container services business at Tilbury, which have been affected by the downturn. Just Retirement confirmed that Avalon Acquisitions is considering a possible offer for the life assurance group.In the press, the FT writes that Alistair Darling is planning a new Banking Act this year that will strengthen the role of the Financial Services Authority, in an unexpected move that follows criticism that the Bank of England failed to warn adequately of the impending banking crisis.

Related Shares

More News
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announ...

3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.